Skip to main content
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Allergan
Latest Articles
U.S. M&A Could Rebound as Companies See Few Other Growth Options
Dan Weil
·
July 6, 2016
The Morning Brief: Icahn Joins Hedgies in Allergan Trade
Stephen Taub
·
June 1, 2016
Golden Parachutes Leave Investors Fearing Conflict of Interest
Jeff Ostrowski
·
May 17, 2016
Perella Weinberg’s Andrew Bednar Drives Stock Exchange Megadeals
David Rothnie
·
April 19, 2016
The Morning Brief: March Gains Trim Hefty Losses at Omega, Glenview
Stephen Taub
·
April 11, 2016
The Morning Brief: Emerging Markets Funds Got a Boost in March
Stephen Taub
·
April 8, 2016
Minding the Gap Between GAAP, Pro Forma Earnings
Dan Weil
March 17, 2016
For Members Only
Jana Partners Continues As It Finished the Year: Down
Stephen Taub
February 2, 2016
The Morning Brief: Alcoa Trades Expanded Board for Elliott’s Support
Stephen Taub
·
February 2, 2016
Inbound M&A Adds Fuel to a Hot Deal Market
Dan Weil
December 23, 2015
Allergan-Pfizer Merger Gives Pharma a Growth Injection
Anne Szustek
December 16, 2015
Daily Agenda: Commodity Rout Continues
Andrew Barber
November 23, 2015
Daily Agenda: Liquidity Fuels Continuing M&A Boom
Andrew Barber
October 30, 2015
Daily Agenda: Gravity Returns to Chinese Stock Market
Andrew Barber
July 27, 2015
The Morning Brief: Elliott Discloses CDK Global Stake
Stephen Taub
·
May 13, 2015
For Members Only
The 2015 Rich List: The Highest Earning Hedge Fund Managers of the Past Year
Stephen Taub
May 5, 2015
For Members Only
Jana Records a Slightly Down March as Volatilty Hits
Stephen Taub
April 1, 2015
Actavis CEO Brent Saunders Has a Vision for Growth
Anne Szustek
March 12, 2015
More Articles